| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.876 | 5.790 | 5.911 | 7.156 | 19.185 | 13.593 | 10.094 | 6.712 | 980 | 985 |
| Total Income - EUR | 2.876 | 5.790 | 5.911 | 7.156 | 19.185 | 13.593 | 10.094 | 6.712 | 980 | 985 |
| Total Expenses - EUR | 2.730 | 5.467 | 5.725 | 6.910 | 15.863 | 13.190 | 6.468 | 6.488 | 839 | 876 |
| Gross Profit/Loss - EUR | 147 | 323 | 185 | 246 | 3.322 | 403 | 3.626 | 224 | 142 | 109 |
| Net Profit/Loss - EUR | 61 | 139 | 7 | 188 | 3.177 | 337 | 3.408 | 157 | 119 | 92 |
| Employees | 0 | 0 | 0 | 0 | 3 | 1 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Pro Bio Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.405 | 1.390 | 1.367 | 1.342 | 5.278 | 5.707 | 5.580 | 5.597 | 5.581 | 5.549 |
| Current Assets | 832 | 947 | 936 | 1.949 | 1.433 | 767 | 4.303 | 4.002 | 3.747 | 4.302 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 175 | 174 | 0 | 0 | 0 | 0 | 2.534 | 3.181 | 1.092 | 3.446 |
| Cash | 657 | 774 | 936 | 1.949 | 1.433 | 767 | 1.769 | 821 | 2.655 | 856 |
| Shareholders Funds | 2.173 | 2.289 | 2.258 | 2.404 | 5.534 | 5.767 | 9.047 | 9.232 | 9.324 | 9.363 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 64 | 49 | 44 | 886 | 1.176 | 707 | 835 | 367 | 4 | 488 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4120 - 4120" | |||||||||
| CAEN Financial Year |
4120
|
|||||||||
Comments - Pro Bio Srl